申请人:Miyata Toshio
公开号:US20110112140A1
公开(公告)日:2011-05-12
The present invention relates to a novel compound having plasminogen activator inhibitor-1 (PAI-1) inhibitory activity, and a PAI-1 inhibitor comprising the compound as an active ingredient. The present invention further relates to a pharmaceutical composition that has an inhibitory action on PAI-1 activity and is useful in the prevention and treatment of various diseases whose onset is associated with PAI-1 activity. The novel compound is represented by the following general formula.
Each symbol is defined as those in the specification.
本发明涉及一种具有纤溶酶原激活因子抑制剂-1(PAI-1)抑制活性的新化合物,以及以该化合物为活性成分的PAI-1抑制剂。本发明还涉及一种具有抑制PAI-1活性并在预防和治疗与PAI-1活性相关的各种疾病方面有用的药物组合物。新化合物由以下一般公式表示,其中每个符号如规范中所定义。